GLP-1-based therapies helped adults with overweight or obesity lose weight mainly by reducing fat mass and visceral adipose ...
Researchers conducted a phase 3 trial to compare the efficacy and safety of synthetic semaglutide with Ozempic® for glycemic ...
Introduction Gestational diabetes mellitus (GDM) is associated with a high risk of adverse perinatal outcomes. We evaluated ...
Clinical Trials Arena on MSN
Ascletis completes subject enrolment in Phase II ASC3 trial
Ascletis expects top line results from the study in the third quarter of 2026.
One in seven stroke patients in India falls in the 18-44 age group, while two in five reach hospital more than 24 hours after ...
More than 1.7 million State Pensioners receive either £76.70 or £114.60 each week through the disability benefit.
U.S. Phase II study is evaluating the efficacy, safety and tolerability of oral small molecule GLP-1R agonist ASC30, a once-daily tablet, in 100 participants with diabetes. - Topline data from the ...
A recent Indian Phase III randomized open-label study has demonstrated that Sun Pharma’s injectable semaglutide is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results